Stem cells. U.S. regulation of stem cells as medical products.
about
Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced TherapyPreclinical biosafety evaluation of cell-based therapies: emerging global paradigmsConcise review: making and using clinically compliant pluripotent stem cell linesConcise review: microfluidic technology platforms: poised to accelerate development and translation of stem cell-derived therapiesResponsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications.Ethics and policy issues for stem cell research and pulmonary medicine.Unproven stem cell-based interventions & physicians' professional obligations; a qualitative study with medical regulatory authorities in Canada.From bench to FDA to bedside: US regulatory trends for new stem cell therapiesChallenges in the translation and commercialization of cell therapies.Wound repair and regeneration: mechanisms, signaling, and translationCell-Mediated Dexamethasone Release from Semi-IPNs Stimulates Osteogenic Differentiation of Encapsulated Mesenchymal Stem CellsThe emerging use of bone marrow-derived mesenchymal stem cells in the treatment of human chronic wounds.Cell therapy worldwide: an incipient revolution.The case for stem cell counselors.Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells.Global regulatory developments for clinical stem cell research: diversification and challenges to collaborations.Identity and ownership issues in the regulation of autologous cells.The effect of adipose stromal vascular fraction on transverse rectus abdominis musculocutaneous flap: an experimental study.
P2860
Q26748517-FF5E1432-5B73-449C-8689-6789F6000A59Q26829230-08DDACE1-DE4C-4DFE-AEE2-E0AFF8D5C428Q26852128-8233A7A4-4A77-403A-AFF9-F1A8BCC69335Q30422115-4BD113E1-D39A-4220-92E2-247E32D3209DQ33659105-BDA5F1F0-81FA-4A13-A395-449C9A8FF7C1Q35190284-A8ACD261-B755-4C7F-A36F-DDBB9962ED74Q35332547-6457E470-0CBC-4622-A7E0-6EC2FB13BC32Q35434093-CEB15863-9910-4332-96EE-C476CB6C142CQ35739401-A4DC4B7F-00B9-4D51-A3AC-319E731BAD68Q37152090-577EE0E1-2384-4CAE-9B3A-E0D23D23F23BQ37702838-069C570A-0030-4C84-8EC9-07672599AE96Q38134137-F19475B6-EC29-410E-8B93-2360099F167DQ38391002-8B294178-9A53-4E40-A397-E4A0D8DBD512Q43109832-348FB11F-F60A-4F13-B2DE-B1FA08F39549Q45001494-8EA4E4E1-4118-4225-A12F-BA6D7308A71AQ47275458-74D48523-2661-46C2-A35F-BD5F645491BBQ47852426-58DEE128-A1F7-46A7-88DF-9B88062E87FEQ51419982-316EB24E-EBAE-4FB0-88BD-F879C45FF662
P2860
Stem cells. U.S. regulation of stem cells as medical products.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Stem cells. U.S. regulation of stem cells as medical products.
@en
Stem cells. U.S. regulation of stem cells as medical products.
@nl
type
label
Stem cells. U.S. regulation of stem cells as medical products.
@en
Stem cells. U.S. regulation of stem cells as medical products.
@nl
prefLabel
Stem cells. U.S. regulation of stem cells as medical products.
@en
Stem cells. U.S. regulation of stem cells as medical products.
@nl
P2860
P356
P1433
P1476
Stem cells. U.S. regulation of stem cells as medical products.
@en
P2860
P304
P356
10.1126/SCIENCE.1229918
P407
P577
2012-12-01T00:00:00Z